Proven, Safe IV Treatment to Improve Circulation and Cell Health and Avoid Surgery
For over 50 years chelation therapy has served as a highly effective and safe intravenous treatment for the elimination of toxic heavy metals and improvement of circulation and health.
IV Chelation therapy is different from other nutrient IVs because it involves the administration of a powerful amino amino called EDTA (Ethylenediaminetetraacetic Acid) that actually detoxes heavy metals. It enters the bloodstream through the IV and catches lead, iron and cadmium that can cause free radical damage to the arteries. These heavy metals are bound to the EDTA and eliminated from the body through the process of urination.
This therapy is great for arteriosclerosis, heavy metal toxicity, memory problems, heart disease, fatigue, circulation problems and more. It has helped restore healthy function and quality of life to our patients, many of whom have been able to prevent the need for painful and costly surgeries or to rely on prescription medications.
This therapy has proven to be clinically significant and safe by the 8-year, $30 million government-funded national study called Trial to Assess Chelation Therapy (TACT).
Chelation Therapy is Beneficial For:
Heart disease: angina & chest pains; arrhythmias; heart attack; stroke
Memory problems or “brain fog”
Hypertension (high blood pressure)
Heavy metal toxicity
Fibromyalgia & autoimmune disorders
Leg cramps / walking problems
Hearing / vision loss
Shortness of breath
Poor circulation / cold feet and hands
Contact Us at
Or Email Us AlaskaAlternativeMedicine@gmail.com
To Find Out How We Can Help You Feel Your Best!
“For 10 years my arthritis was bad and getting worse. After chelation my arms, shoulders and hands are loose and I have feeling in them again. My legs are loose and I can stand up and walk without pain for the first time in years. Chelation is what has accomplished this miracle!“
- Robert Cunningham, age 78
Resources and Additional Information
Unleaded: The Movie Trailer
The revolutionary results of the 10 year
$31 million National Institutes of Health TACT study on Chelation therapy.